Thomas Hope
Clinical trials sponsored by Thomas Hope, explained in plain language.
-
Scientists test two powerful radiation beams to shrink prostate tumors before removal
Disease control Recruiting nowThis early-stage study is comparing two different targeted radiation drugs for men with high-risk prostate cancer who are planning to have surgery. The goal is to see which drug might be more effective at delivering radiation to the tumor and potentially priming the immune system…
Phase: PHASE1 • Sponsor: Thomas Hope • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Special scan offered to pinpoint troubling neck gland
Diagnosis AVAILABLEThis program provides expanded access to a specific type of PET scan for patients at UCSF. The scan uses a tracer called 18F-fluorocholine to help doctors find and locate parathyroid adenomas, which are small, overactive glands in the neck. It is for patients aged 13 and older wh…
Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
New scan could spot hidden cancer spread
Diagnosis Recruiting nowThis early-stage trial is testing a new imaging tracer called FAP-2286 to see if it can better detect cancer that has spread (metastasized) in people with solid tumors. The study will enroll about 191 adults with cancers like breast, prostate, pancreatic, and colon cancer. Resear…
Phase: PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC
-
New scan could spot hidden thyroid cancer better
Diagnosis Recruiting nowThis study is testing whether a new type of PET scan using a radioactive tracer called I-124 can find thyroid cancer that has spread (metastasized) more accurately than the current standard scans (I-123 or I-131). Researchers will compare the new scan results to the standard ones…
Phase: PHASE2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 18, 2026 14:41 UTC